SynthesisFrontiers in medicine2026
Prevalence of depression and anxiety among individuals with preserved ratio impaired spirometry: a systematic review and meta-analysis.
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
At present, the preserved ratio impaired spirometry (PRISm) phenotype is attracting the attention of researchers as a new type of lung function impairment. Although its association with cardiovascular and metabolic diseases has been well studied, its link with mental disorders is not fully understood. Therefore, it is necessary to systematically assess the prevalence of depression and anxiety in people with PRISm. This systematic review and meta-analysis was registered in the PROSPERO database (CRD420261353805). Literature was searched in the Scopus and Web of Science, PubMed databases. Cross-sectional or cohort studies were included if the PRISm phenotype was defined by FEV1/FVC ≥ 0.70 and FEV1 < 80% predicted, and if the prevalence of depression or anxiety was reported in numerical form. Data were extracted by two independent reviewers, and pooled prevalence was calculated using a random-effects model. A total of 6 studies (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.